1 – 9 of 9
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia : a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
(
- Contribution to journal › Article
- 2020
-
Mark
A combined effect of anti-HPA-1a and anti-HLA Class I in pregnancy?
(
- Contribution to journal › Article
-
Mark
Fetal/neonatal alloimmune thrombocytopenia : A systematic review of impact of HLA-DRB3∗01:01 on fetal/neonatal outcome
(
- Contribution to journal › Scientific review
- 2019
-
Mark
HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a–immunized women
(
- Contribution to journal › Article
-
Mark
Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia : a systematic review
(
- Contribution to journal › Article
-
Mark
Fetal and neonatal alloimmune thrombocytopenia : recommendations for evidence-based practice, an international approach
(
- Contribution to journal › Article
-
Mark
Postnatal intervention for the treatment of FNAIT : a systematic review
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Screening for fetal and neonatal alloimmune thrombocytopenia - lessons learned from a Norwegian screening program
(
- Contribution to journal › Letter
- 2017
-
Mark
Antenatal management in fetal and neonatal alloimmune thrombocytopenia : A systematic review
(
- Contribution to journal › Scientific review